These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 226864)

  • 1. Stereospecific opiate binding in bovine adrenal medulla.
    Chavkin C; Cox BM; Goldstein A
    Mol Pharmacol; 1979 May; 15(3):751-3. PubMed ID: 226864
    [No Abstract]   [Full Text] [Related]  

  • 2. [Direct interaction of tricyclic antidepressants with opiate binding sites in the bovine adrenal medulla].
    Carydakis C; Bourhim N; Giraud P; Cantau P; Oliver C; Castanas E
    C R Acad Sci III; 1986; 302(11):419-22. PubMed ID: 3013380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of (+)-[3H]3-PPP and [3H]TCP binding sites in membrane preparations of bovine adrenal medulla.
    Rogers CA; Lemaire S
    Prog Clin Biol Res; 1990; 328():133-6. PubMed ID: 2154767
    [No Abstract]   [Full Text] [Related]  

  • 4. Photoaffinity crosslinking of etorphine with opioid binding sites in the bovine adrenal medulla.
    Cantau P; Bourhim N; Giraud P; Oliver C; Castanas E
    Biotechnol Appl Biochem; 1987 Apr; 9(2):114-22. PubMed ID: 3036179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal medullary opioid receptors are linked to GTP-binding proteins, pertussis toxin substrates.
    Kamikubo K; Murase H; Niwa M; Miura K; Nozaki M; Tsurumi K
    NIDA Res Monogr; 1986; 75():129-32. PubMed ID: 2828956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
    Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
    Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites.
    Leslie FM; Chavkin C; Cox BM
    J Pharmacol Exp Ther; 1980 Aug; 214(2):395-402. PubMed ID: 6248635
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics of peptide and alkaloid opiate binding sites in brain and peripheral tissues.
    Cox BM; Leslie FM; Chavkin C
    Adv Biochem Psychopharmacol; 1980; 22():353-62. PubMed ID: 6249080
    [No Abstract]   [Full Text] [Related]  

  • 9. Opiate binding sites spectrum on bovine adrenal medullas and six human pheochromocytomas.
    Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
    Life Sci; 1983; 33 Suppl 1():295-8. PubMed ID: 6319880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic studies on binding of [3H] beta-funaltrexamine ([3H] beta-FNA) to mu opioid receptors.
    Liu-Chen LY; Li S; Holowecky O; Tallarida RJ
    Prog Clin Biol Res; 1990; 328():57-60. PubMed ID: 2154818
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on membrane-bound opiate receptors.
    Simon EJ
    Prog Clin Biol Res; 1979; 27():51-62. PubMed ID: 218233
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone.
    Wentland MP; Lu Q; Lou R; Bu Y; Knapp BI; Bidlack JM
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2107-10. PubMed ID: 15808478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate receptor binding in the pituitary gland.
    Simantov R; Snyder SH
    Brain Res; 1977 Mar; 124(1):178-84. PubMed ID: 191146
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding of a new opiate antagonist, nalmefene, to rat brain membranes.
    Michel ME; Bolger G; Weissman BA
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):175-7. PubMed ID: 2991678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of acetylcholine receptors by endogenous cotransmitters: studies of adrenal medulla.
    Costa E; Guidotti A; Hanbauer I; Hexum T; Saiani L; Stine S; Yang HY
    Fed Proc; 1981 Feb; 40(2):160-5. PubMed ID: 6257555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enkephalin, endorphin, and the opiate receptor.
    Tregear GW; Coghlan JP
    Circ Res; 1980 Jun; 46(6 Pt 2):I142-8. PubMed ID: 6247086
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
    Liu-Chen LY; Li SX; Tallarida RJ
    Mol Pharmacol; 1990 Feb; 37(2):243-50. PubMed ID: 2154672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for the opiate peptides that presumably coexist with acetylcholine in splanchnic nerves.
    Kumakura K; Guidotti A; Yang HY; Saiani L; Costa E
    Adv Biochem Psychopharmacol; 1980; 22():571-80. PubMed ID: 6249085
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple molecular forms of stereospecific opiate binding.
    Smith AP; Loh HH
    Mol Pharmacol; 1979 Nov; 16(3):757-66. PubMed ID: 43467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.